eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | li-fraumeni syndrome |
| Comorbidity | C0007131|non-small cell lung cancer |
| Sentences | 5 |
| PubMedID- 21129811 | This study was conducted to identify genetic factors predisposing to tp53 mutations in patients with non-small cell lung cancer (nsclc). |
| PubMedID- 22524618 | Methods: dld-1 cells (a human colorectal cancer cell line) and h1299 cells (a non-small cell lung cancer cell line) with differences of p53 gene status were used. |
| PubMedID- 25962159 | For example, the mutation rate of p53 gene in non-small cell lung cancer (nsclc) can reach to 60%, even goes up to 80% in small cell lung cancer (sclc) [5]. |
| PubMedID- 22008105 | [high resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer]. |
| PubMedID- 25594032 | In this study, we identified the pict1 protein expression profile in non-small cell lung cancer (nsclc) with wild-type tp53 in the nucleolus and cytoplasm, and revealed the relationship between pict1 expression and patient clinicopathological factors. |
Page: 1